Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$8.61 - $11.04 $5.08 Million - $6.51 Million
-590,000 Reduced 98.33%
10,000 $97,000
Q3 2019

Nov 14, 2019

BUY
$6.16 - $9.6 $616,000 - $960,000
100,000 Added 20.0%
600,000 $4.13 Million
Q2 2019

Aug 14, 2019

BUY
$8.12 - $15.72 $4.06 Million - $7.86 Million
500,000 New
500,000 $4.62 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track Bill Miller's Portfolio

Track Bill Miller Portfolio

Follow Bill Miller (Miller Value Partners, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Miller Value Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miller Value Partners, LLC and Bill Miller with notifications on news.